Your browser doesn't support javascript.
loading
A new monoclonal antibody that blocks dimerisation and inhibits c-kit mutation-driven tumour growth.
Bai, Chenguang; Xu, Yi; Qiu, Cen.
Affiliation
  • Bai C; Department of Pathology, Changhai Hospital, Second Military Medical University, Shanghai, China.
  • Xu Y; Department of Pathology, Yueyang Integrative Medicine Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Qiu C; Department of Pathology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Number 639 Zhizaoju Rd., Shanghai, 200001, China. qiucendeviant@163.com.
J Cancer Res Clin Oncol ; 147(4): 1065-1075, 2021 Apr.
Article in En | MEDLINE | ID: mdl-33389076
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Gene Expression Regulation, Neoplastic / Proto-Oncogene Proteins c-kit / Protein Multimerization / Antibodies, Monoclonal / Mutation / Neoplasms Limits: Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Gene Expression Regulation, Neoplastic / Proto-Oncogene Proteins c-kit / Protein Multimerization / Antibodies, Monoclonal / Mutation / Neoplasms Limits: Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2021 Document type: Article Affiliation country: Country of publication: